COR vs. MCK, CAH, HSIC, PDCO, OMI, HLF, NUS, COSM, HWH, and MEDS
Should you be buying Cencora stock or one of its competitors? The main competitors of Cencora include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Owens & Minor (OMI), Herbalife (HLF), Nu Skin Enterprises (NUS), Cosmos Health (COSM), HWH International (HWH), and TRxADE HEALTH (MEDS).
Cencora vs.
Cencora (NYSE:COR) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, community ranking, valuation and earnings.
In the previous week, McKesson had 3 more articles in the media than Cencora. MarketBeat recorded 37 mentions for McKesson and 34 mentions for Cencora. McKesson's average media sentiment score of 1.53 beat Cencora's score of 1.41 indicating that McKesson is being referred to more favorably in the news media.
Cencora has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Comparatively, McKesson has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500.
97.5% of Cencora shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 10.8% of Cencora shares are owned by insiders. Comparatively, 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
McKesson has a net margin of 0.82% compared to Cencora's net margin of 0.46%. Cencora's return on equity of 328.62% beat McKesson's return on equity.
McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.
Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.8%. McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.4%. Cencora pays out 31.3% of its earnings in the form of a dividend. McKesson pays out 13.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has raised its dividend for 15 consecutive years and McKesson has raised its dividend for 17 consecutive years.
Cencora presently has a consensus target price of $280.20, indicating a potential upside of 1.90%. McKesson has a consensus target price of $649.36, indicating a potential downside of 2.35%. Given Cencora's higher possible upside, research analysts clearly believe Cencora is more favorable than McKesson.
McKesson received 226 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 74.27% of users gave McKesson an outperform vote while only 65.30% of users gave Cencora an outperform vote.
Summary
McKesson beats Cencora on 15 of the 22 factors compared between the two stocks.
Get Cencora News Delivered to You Automatically
Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools
This page (NYSE:COR) was last updated on 3/28/2025 by MarketBeat.com Staff